Company Reports

Recent Updates

All Reports

Stock Analyst Note

Experian reported 7% organic revenue growth in the first half of fiscal 2027. It slightly lowered its organic revenue growth outlook for the fiscal year ending March 2027. Shares finished the London session up 2%.
Stock Analyst Note

In its fiscal first-quarter trading update, Experian reported 7% organic revenue growth, consistent with its full-year 6%-8% outlook. As is often the case, the company left its outlook unchanged after the first quarter.
Stock Analyst Note

Fair Isaac shares fell 21% between March 9 and March 11, underperforming peers TransUnion (down 7%) and Equifax (down 8%) as well as the Morningstar US Market Index (up 1%) over the same period.
Stock Analyst Note

In intraday trading on Feb. 3, a broad group of information-services companies, such as rating agencies, data providers, index providers, credit bureaus, and others, are seeing share price declines of 5% or more.
Stock Analyst Note

Experian reported organic revenue growth of 8% during its fiscal third-quarter update, consistent with the 9% and 8% growth seen in the second and first quarters, respectively. Experian also maintained its fiscal 2026 outlook. Shares of Experian finished the London session down 5%.
Stock Analyst Note

Wide-moat Experian was mostly steady in the firm’s fiscal third quarter. Organic revenue grew 6%, roughly in line with the 7% reported in the first and second quarters. We note that the prior-year period had some increased breach activity, which can be lumpy. Given these steady results, Experian did not alter its revenue and margin outlook for fiscal 2025. As we incorporate these results, we will maintain our fair value estimate of $50 (GBX 3,900) per share and view shares as modestly undervalued.
Stock Analyst Note

Wide-moat Experian was mostly steady in its second fiscal quarter. Organic revenue grew 7% in the second quarter, the same rate as the first quarter. Overall, there was little in the earnings release that would alter our long-term view of the firm. As we incorporate its results, we will maintain our fair value estimate of GBX 3,900 and regard shares as being roughly fairly valued.

Sponsor Center